Medy-Tox Inc. is a biopharmaceutical company.  The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.

Closure of Register of Shareholders or Designation of Record Date

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medy Tox Inc (086900 KS)

Closure of Register of Shareholders or Designation of Record Date

Decision on Acquisition of Treasury Stock

Decision on Acquisition of Treasury Stock

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

[Revised] Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)